aclatonium

This page covers all aclatonium drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Muscarinic acetylcholine receptor.

Targets

Muscarinic acetylcholine receptor

Phase 2 pipeline (1)

• Abovis · Dermatology
  Abovis works by binding to the muscarinic acetylcholine receptor, a protein that plays a key role in regulating various bodily functions.

Patent intelligence

• aclatonium patent landscape — aggregated cliff calendar, attackable patents, originator estates